| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J Steven Lamberti, David Olson, John F Crilly, Telva Olivares, Geoffrey C Williams, Xin Tu, Wan Tang, Karen Wiener, Steven Dvorin, Marci B Diet. Prevalence of the metabolic syndrome among patients receiving clozapine. The American journal of psychiatry. vol 163. issue 7. 2006-08-10. PMID:16816234. |
this study compared the prevalence of the metabolic syndrome among outpatients with schizophrenia and schizoaffective disorder receiving clozapine with a matched comparison group from the national health and nutrition examination survey. |
2006-08-10 |
2023-08-12 |
Not clear |
| D C Henderson, L Kunkel, D D Nguyen, C P Borba, T B Daley, P M Louie, O Freudenreich, C Cather, A E Evins, D C Gof. An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. Acta psychiatrica Scandinavica. vol 113. issue 2. 2006-08-02. PMID:16423166. |
an exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. |
2006-08-02 |
2023-08-12 |
human |
| David C Henderson, Paul M Copeland, Christina P Borba, Tara B Daley, Dana D Nguyen, Enrico Cagliero, A Eden Evins, Hui Zhang, Doug L Hayden, Oliver Freudenreich, Corinne Cather, David A Schoenfeld, Donald C Gof. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. The Journal of clinical psychiatry. vol 67. issue 5. 2006-08-02. PMID:16841629. |
clozapine and olanzapine treatment has been associated with insulin resistance in non-obese schizophrenia patients. |
2006-08-02 |
2023-08-12 |
Not clear |
| Neil D Woodward, Scot E Purdon, Herbert Y Meltzer, David H Zal. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. The international journal of neuropsychopharmacology. vol 8. issue 3. 2006-07-19. PMID:15784157. |
a meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. |
2006-07-19 |
2023-08-12 |
human |
| Tomiki Sumiyoshi, Dai Jin, Karu Jayathilake, Myung Lee, Herbert Y Meltze. Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia. The international journal of neuropsychopharmacology. vol 8. issue 3. 2006-07-19. PMID:15817136. |
prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia. |
2006-07-19 |
2023-08-12 |
human |
| Tomiki Sumiyoshi, Dai Jin, Karu Jayathilake, Myung Lee, Herbert Y Meltze. Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia. The international journal of neuropsychopharmacology. vol 8. issue 3. 2006-07-19. PMID:15817136. |
the aim of the present study was to determine if glycine, or its ratio to serine, a precursor of glycine, predicts change in negative symptoms in subjects with schizophrenia during treatment with clozapine, an atypical antipsychotic drug with multiple effects on glutamatergic activity. |
2006-07-19 |
2023-08-12 |
human |
| Tomiki Sumiyoshi, Dai Jin, Karu Jayathilake, Myung Lee, Herbert Y Meltze. Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia. The international journal of neuropsychopharmacology. vol 8. issue 3. 2006-07-19. PMID:15817136. |
plasma levels of glycine, serine, and their ratio, were measured in 44 patients with schizophrenia who were subsequently treated with clozapine. |
2006-07-19 |
2023-08-12 |
human |
| Tomiki Sumiyoshi, Dai Jin, Karu Jayathilake, Myung Lee, Herbert Y Meltze. Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia. The international journal of neuropsychopharmacology. vol 8. issue 3. 2006-07-19. PMID:15817136. |
these results indicate the association of these amino acid measures with response to clozapine in terms of negative symptoms in patients with schizophrenia. |
2006-07-19 |
2023-08-12 |
human |
| Clarissa Severino Gama, Mirian Salvador, Ana Cristina Andreazza, Flavio Kapczinski, Paulo Silva Belmonte-de-Abre. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 3. 2006-07-19. PMID:16426720. |
elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. |
2006-07-19 |
2023-08-12 |
Not clear |
| Stevin Zung, Marcelo Hong, Gabriella Fort. [Agranulocytosis induced by interferon-alpha and ribavirin in a patient with schizophrenia using clozapine]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). vol 28. issue 1. 2006-07-10. PMID:16612501. |
[agranulocytosis induced by interferon-alpha and ribavirin in a patient with schizophrenia using clozapine]. |
2006-07-10 |
2023-08-12 |
Not clear |
| Sungwon Roh, Dong Hyun Ahn, Jung Hyun Nam, Byung Hwan Yang, Bang Hun Lee, Yang Suk Ki. Cardiomyopathy associated with clozapine. Experimental and clinical psychopharmacology. vol 14. issue 1. 2006-06-29. PMID:16503709. |
clozapine is an atypical antipsychotic agent that is more effective than the standard neuroleptics currently used for treating refractory schizophrenia. |
2006-06-29 |
2023-08-12 |
Not clear |
| Sungwon Roh, Dong Hyun Ahn, Jung Hyun Nam, Byung Hwan Yang, Bang Hun Lee, Yang Suk Ki. Cardiomyopathy associated with clozapine. Experimental and clinical psychopharmacology. vol 14. issue 1. 2006-06-29. PMID:16503709. |
this report describes a 31-year-old korean male patient with schizophrenia who developed dilated cardiomyopathy on treatment with clozapine. |
2006-06-29 |
2023-08-12 |
Not clear |
| Mark A Geye. Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia? Dialogues in clinical neuroscience. vol 8. issue 1. 2006-06-28. PMID:16640109. |
similarly, both ppi and cognitive deficits in schizophrenia patients are insensitive to first-generation antipsychotics, but attenuated by clozapine. |
2006-06-28 |
2023-08-12 |
human |
| Alexandra L Sporn, Aaron J Bobb, Nitin Gogtay, Hanna Stevens, Deanna K Greenstein, Liv S Clasen, Julia W Tossell, Thomas Nugent, Peter A Gochman, Wendy S Sharp, Anand Mattai, Marge C Lenane, Jack A Yanovski, Judith L Rapopor. Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study. Journal of the American Academy of Child and Adolescent Psychiatry. vol 44. issue 9. 2006-06-09. PMID:16113621. |
in this study, the authors examined six weight gain-related hormones in patients with childhood-onset schizophrenia (cos) after 6 weeks of clozapine treatment. |
2006-06-09 |
2023-08-12 |
Not clear |
| Harriet J Williams, Christina R Zamzow, Harold Robertson, Serdar M Dursu. Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16303224. |
there is growing evidence from both uncontrolled and controlled clinical studies that lamotrigine (ltg) significantly augments clozapine (clz) in the treatment of refractory schizophrenia (rs) [dursun, s.m., mcintosh, d., milliken, h., 1999. |
2006-06-08 |
2023-08-12 |
rat |
| Harriet J Williams, Christina R Zamzow, Harold Robertson, Serdar M Dursu. Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16303224. |
clozapine plus lamotrigine in treatment-resistant schizophrenia. |
2006-06-08 |
2023-08-12 |
rat |
| Jong-Hoon Kim, Seong-Youn Kim, Yong Min Ahn, Yong Sik Ki. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16309807. |
subjective response to clozapine and risperidone treatment in outpatients with schizophrenia. |
2006-06-08 |
2023-08-12 |
human |
| Jessica Oi-Yin Wong, Shung-pun Leung, Tony Mak, Roger Man-kin Ng, Kai-tai Chan, Henry Hon-Kee Cheung, Wing-kit Choi, Judy Lai, Alfert Wai-Kiu Tsan. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16316716. |
to evaluate clinical efficacy of clozapine in relation with its plasma level in a group of chinese patients with treatment-resistant schizophrenia. |
2006-06-08 |
2023-08-12 |
Not clear |
| Edward D Levin, N Channelle Christophe. Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16356617. |
effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia. |
2006-06-08 |
2023-08-12 |
rat |
| Edward D Levin, N Channelle Christophe. Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16356617. |
clozapine is an effective atypical antipsychotic drug used to treat schizophrenia. |
2006-06-08 |
2023-08-12 |
rat |